Literature DB >> 12359306

Interactions between the juxtamembrane domain of the EGFR and calmodulin measured by surface plasmon resonance.

Sami Aifa1, Knut Johansen, Ulrika K Nilsson, Bo Liedberg, Ingemar Lundström, Samuel P S Svensson.   

Abstract

One early response to epidermal growth factor receptor (EGFR) activation is an increase in intracellular calcium. We have used surface plasmon resonance (SPR) to study real-time interactions between the intracellular juxtamembrane (JM) region of EGFR and calmodulin. The EGFR-JM (Met(644)-Phe(688)) was expressed as a GST fusion protein and immobilised on a sensor chip surface. Calmodulin specifically interacts with EGFR-JM in a calcium-dependent manner with a high on and high off rate. Chemical modification of EGFR-JM by using arginine-selective phenylglyoxal or deletion of the basic segment Arg(645)-Arg(657) inhibits the interaction. Phosphorylation of EGFR-JM by protein kinase C (PKC) or glutamate substitution of Thr(654) inhibits the interaction, suggesting that PKC phosphorylation electrostatically interferes with calmodulin binding to basic arginine residues. Calmodulin binding was also inhibited by suramin. Our results suggest that EGFR-JM is essential for epidermal growth factor (EGF)-mediated calcium-calmodulin signalling and for signal integration between other signalling pathways. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359306     DOI: 10.1016/s0898-6568(02)00034-7

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

Review 1.  Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.

Authors:  Edwin Li; Kalina Hristova
Journal:  Cell Adh Migr       Date:  2010-04-23       Impact factor: 3.405

2.  Calmodulin binds HER2 and modulates HER2 signaling.

Authors:  Colin D White; Zhigang Li; David B Sacks
Journal:  Biochim Biophys Acta       Date:  2010-12-24

3.  An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.

Authors:  Stuart McLaughlin; Steven O Smith; Michael J Hayman; Diana Murray
Journal:  J Gen Physiol       Date:  2005-06-13       Impact factor: 4.086

4.  Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin.

Authors:  Hongbing Li; Svetlana Panina; Amandeep Kaur; María J Ruano; Pablo Sánchez-González; Jonas M la Cour; Alexander Stephan; Uffe H Olesen; Martin W Berchtold; Antonio Villalobo
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

5.  The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.

Authors:  Hongbing Li; Juan Sánchez-Torres; Alan Del Carpio; Valentina Salas; Antonio Villalobo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

6.  Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay.

Authors:  Afshan Kaleem; Ishtiaq Ahmad; Daniel C Hoessli; Evelyne Walker-Nasir; Muhammad Saleem; Abdul Rauf Shakoori
Journal:  Mol Biol Rep       Date:  2008-03-14       Impact factor: 2.316

7.  CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma.

Authors:  Tao Liu; Xiujuan Han; Shutao Zheng; Qing Liu; Aerziguli Tuerxun; Qiqi Zhang; Lifei Yang; Xiaomei Lu
Journal:  Cancer Cell Int       Date:  2021-02-18       Impact factor: 5.722

8.  In vitro activation and inhibition of recombinant EGFR tyrosine kinase expressed in Escherichia coli.

Authors:  Jihene Elloumi-Mseddi; Karim Jellali; Sami Aifa
Journal:  ScientificWorldJournal       Date:  2013-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.